SPART-AS1
Putative uncharacterized protein SPART-AS1
Also known as: SPGOS_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for SPART-AS1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
52 residues, UniProt reviewed canonical sequence.
>P0CW21|SPART-AS1
1 MKDIGHLQHL AQRLQWNRRA VNICGMHGWT KDLSPHSRMP SMLEHVKHYM SCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPART-AS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPART-AS1 as an antibody target. Whether an autoantibody or antibody against SPART-AS1 could matter depends on whether native SPART-AS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPART-AS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPART-AS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...